MAPT and Alzheimer disease: Although pathologic Aβ is the prevalent toxic event in AD according to the amyloid cascade hypothesis, clearance of Aβ alone may be insufficient to stop/delay the disease progress especially in the later stages of AD, while accumulating evidence shows that pathologic tau may also correlate with disease pathogenesis and progression [34].